XML 41 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Revision of Previously Issued Financial Statements

To correct the misstatements above, the Company revised its previously issued financial statements as follows:

 

 

 

As of December 31, 2021

 

CONSOLIDATED BALANCE SHEET

 

As Previously Reported

 

 

Adjustments

 

 

As Revised

 

Deferred revenue, current

 

$

4,557,317

 

 

$

60,105

 

 

$

4,617,422

 

     Current liabilities

 

$

6,030,547

 

 

$

60,105

 

 

$

6,090,652

 

Deferred revenue, net of current portion

 

$

1,578,769

 

 

$

185,480

 

 

$

1,764,249

 

     Total liabilities

 

$

11,250,221

 

 

$

245,585

 

 

$

11,495,806

 

Accumulated deficit

 

$

(123,462,638

)

 

$

(245,585

)

 

$

(123,708,223

)

     Stockholders' deficit

 

$

(12,965,983

)

 

$

(245,585

)

 

$

(13,211,568

)

     Total liabilities and stockholders' deficit

 

$

12,668,626

 

 

$

 

 

$

12,668,626

 

 

 

 

For the Year Ended December 31, 2021

 

CONSOLIDATED STATEMENT OF OPERATIONS

 

As Previously Reported

 

 

Adjustments

 

 

As Revised

 

     Product revenue

 

$

7,254,471

 

 

$

(266,404

)

 

$

6,988,067

 

     Support and services revenue

 

$

6,926,009

 

 

$

20,819

 

 

$

6,946,828

 

     Total revenue

 

$

14,180,480

 

 

$

(245,585

)

 

$

13,934,895

 

Gross profit

 

$

12,228,204

 

 

$

(245,585

)

 

$

11,982,619

 

Operating income (loss)

 

$

633,868

 

 

$

(245,585

)

 

$

388,283

 

     Income (loss) before income taxes

 

$

730,095

 

 

$

(245,585

)

 

$

484,510

 

     Net income (loss)

 

$

203,332

 

 

$

(245,585

)

 

$

(42,253

)

     Net income (loss) attributable to common stockholders

 

$

(1,240,334

)

 

$

(245,585

)

 

$

(1,485,919

)

Basic net income (loss) per share attributable to common stockholders

 

$

(0.19

)

 

$

(0.04

)

 

$

(0.23

)

Diluted net income (loss) per share attributable to common stockholders

 

$

(0.19

)

 

$

(0.04

)

 

$

(0.23

)

 

 

 

For the Year Ended December 31, 2021

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)

 

As Previously Reported

 

 

Adjustments

 

 

As Revised

 

Net income (loss)

 

$

203,332

 

 

$

(245,585

)

 

$

(42,253

)

Total comprehensive income (loss)

 

$

331,253

 

 

$

(245,585

)

 

$

85,668

 

Total comprehensive income (loss) attributable to common stockholders

 

$

(1,112,413

)

 

$

(245,585

)

 

$

(1,357,998

)

 

 

 

Total Stockholders' Deficit

 

CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT

 

As Previously Reported

 

 

Adjustments

 

 

As Revised

 

Balance at December 31, 2020

 

$

(15,540,812

)

 

$

 

 

$

(15,540,812

)

Net income (loss)

 

$

203,332

 

 

$

(245,585

)

 

$

(42,253

)

Balance at December 31, 2021

 

$

(12,965,983

)

 

$

(245,585

)

 

$

(13,211,568

)

 

 

 

 

For the Year Ended December 31, 2021

 

CONSOLIDATED STATEMENT OF CASH FLOWS

 

As Previously Reported

 

 

Adjustments

 

 

As Revised

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

203,332

 

 

$

(245,585

)

 

$

(42,253

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

Deferred revenue

 

$

(899,183

)

 

$

245,585

 

 

$

(653,598

)

Net cash provided by (used in) operating activities

 

$

(883,529

)

 

$

 

 

$

(883,529

)

Schedule of Changes in Deferred Revenue

Changes in deferred revenue were as follows:

 

Year Ended December 31, 2022

 

 

 

Balance at December 31, 2021

 

$

6,381,671

 

Deferral of revenue

 

 

8,642,479

 

Recognition of revenue

 

 

(10,052,248

)

Change in reserves

 

 

(6,053

)

Balance at December 31, 2022

 

$

4,965,849

 

Right of Use Assets and Liabilities and Lease Costs

We have various operating leases for office facilities that are expected to continue through 2023. Below is a summary of our ROU assets and liabilities as of December 31, 2022.

 

Right of use assets

 

$

34,416

 

Total lease liability obligations, current

 

$

34,416

 

Weighted-average remaining lease term

 

0.5

 

Weighted-average discount rate

 

 

3.35

%

 

 

 

 

Years Ended December 31,

 

 

 

 

2022

 

 

 

2021

 

Components of lease expense:

 

 

 

 

 

 

Operating lease cost

 

$

142,388

 

 

$

766,952

 

Sublease income

 

 

 

 

 

(100,418

)

Net lease cost

 

$

142,388

 

 

$

666,534

 

Summary of Future Minimum Lease Payments of ROU Assets over Remaining Lease

Approximate future minimum lease payments for our ROU assets over the remaining lease periods as of December 31, are as follows:

2023

 

$

34,753

 

Thereafter

 

 

 

Total minimum lease payments

 

 

34,753

 

Less interest

 

 

(337

)

Present value of lease liabilities

 

$

34,416

 

Schedule of Gross Carrying Amount and Accumulated Amortization of Goodwill and Other Intangible Assets

The gross carrying amount and accumulated amortization of goodwill and other intangible assets as of December 31, 2022 and 2021 are as follows:

 

 

 

December 31, 2022

 

 

December 31, 2021

 

Goodwill

 

$

4,150,339

 

 

$

4,150,339

 

Other intangible assets:

 

 

 

 

 

 

Gross carrying amount

 

$

4,041,216

 

 

$

4,038,138

 

Accumulated amortization

 

 

(4,021,130

)

 

 

(3,986,776

)

Net carrying amount

 

$

20,086

 

 

$

51,362

 

Summary of Software Development Costs The gross carrying amount and accumulated amortization of software development costs as of December 31, 2022 and 2021 are as follows:

 

 

 

December 31, 2022

 

 

December 31, 2021

 

Software development costs:

 

 

 

 

 

 

Gross carrying amount

 

$

3,015,132

 

 

$

2,980,132

 

Accumulated amortization

 

 

(2,962,075

)

 

 

(2,937,437

)

Software development costs, net

 

$

53,057

 

 

$

42,695

 

Schedule of Anti-dilutive Common Stock Equivalents that were Excluded from Computation of Diluted Shares Outstanding

The following represents the common stock equivalents that were excluded from the computation of diluted shares outstanding because their effect would have been anti-dilutive for the years ended December 31, 2022 and 2021:

 

 

 

Year Ended December 31,

 

 

2022

 

2021

Stock options, warrants and restricted stock

 

37,733

 

77,847

Series A redeemable convertible preferred stock

 

155,963

 

141,385

Total anti-dilutive common stock equivalents

 

193,696

 

219,232

Computation of Earnings Per Share

The following represents a reconciliation of the numerators and denominators of the basic and diluted EPS computation:

 

 

 

Year Ended December 31,

 

 

2022

 

2021

Numerator:

 

 

 

 

Net income (loss)

 

$(1,798,955)

 

$(42,253)

Effects of Series A redeemable convertible preferred stock:

 

 

 

 

Less: Accrual of Series A redeemable convertible preferred stock dividends

 

1,494,057

 

1,143,697

Less: Accretion to redemption value of Series A redeemable convertible preferred stock

 

49,573

 

299,969

Net income (loss) attributable to common stockholders

 

$(3,342,585)

 

$(1,485,919)

 

 

 

 

 

Denominator:

 

 

 

 

Weighted average basic shares outstanding

 

7,100,929

 

6,515,274

Weighted average diluted shares outstanding

 

7,100,929

 

6,515,274

 

 

 

 

 

EPS:

 

 

 

 

Basic net income (loss) per share attributable to common stockholders

 

$(0.47)

 

$(0.23)

Diluted net income (loss) per share attributable to common stockholders

 

$(0.47)

 

$(0.23)